These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27476543)

  • 21. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
    Patel N; Nakrani H; Raval M; Sheth N
    Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering of polymer-surfactant nanoparticles of doxycycline hydrochloride for ocular drug delivery.
    Pokharkar V; Patil V; Mandpe L
    Drug Deliv; 2015; 22(7):955-68. PubMed ID: 24601827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study.
    Emad Eldeeb A; Salah S; Ghorab M
    Drug Deliv; 2019 Dec; 26(1):509-521. PubMed ID: 31090464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycoside-based niosomal nanocarrier for enhanced in-vivo performance of Cefixime.
    Imran M; Shah MR; Ullah F; Ullah S; Elhissi AM; Nawaz W; Ahmad F; Sadiq A; Ali I
    Int J Pharm; 2016 May; 505(1-2):122-32. PubMed ID: 27050867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gellan Gum Based
    Janga KY; Tatke A; Dudhipala N; Balguri SP; Ibrahim MM; Maria DN; Jablonski MM; Majumdar S
    J Pharmacol Exp Ther; 2019 Sep; 370(3):814-822. PubMed ID: 30872389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.
    Rasul A; Imran Khan M; Ur Rehman M; Abbas G; Aslam N; Ahmad S; Abbas K; Akhtar Shah P; Iqbal M; Ahmed Al Subari AM; Shaheer T; Shah S
    Int J Nanomedicine; 2020; 15():7937-7949. PubMed ID: 33116510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical versatility of cationic niosomes derived from amino acid-based surfactants: Skin penetration behavior and controlled drug release.
    Muzzalupo R; Pérez L; Pinazo A; Tavano L
    Int J Pharm; 2017 Aug; 529(1-2):245-252. PubMed ID: 28668583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation: in-vitro characterization and in-vivo evaluation.
    Mohsen AM; AbouSamra MM; ElShebiney SA
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1254-1264. PubMed ID: 28330377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system.
    Gugleva V; Titeva S; Rangelov S; Momekova D
    Int J Pharm; 2019 Aug; 567():118431. PubMed ID: 31207279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin.
    Ullah S; Shah MR; Shoaib M; Imran M; Elhissi AM; Ahmad F; Ali I; Shah SW
    Drug Deliv; 2016 Nov; 23(9):3480-3491. PubMed ID: 27247018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability.
    Zidan AS; Mokhtar Ibrahim M; Megrab NAE
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate.
    Allam A; Fetih G
    Drug Des Devel Ther; 2016; 10():2421-33. PubMed ID: 27536063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive evaluation of formulation factors for ocular penetration of fluoroquinolones in rabbits using cassette dosing technique.
    Sharma C; Biswas NR; Ojha S; Velpandian T
    Drug Des Devel Ther; 2016; 10():811-23. PubMed ID: 26955263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photostability and ex-vivo permeation studies on diclofenac in topical niosomal formulations.
    Ioele G; Tavano L; De Luca M; Ragno G; Picci N; Muzzalupo R
    Int J Pharm; 2015 Oct; 494(1):490-7. PubMed ID: 26307262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Ex Vivo Evaluation of Moxifloxacin Nanostructured Lipid Carrier Enriched In Situ Gel for Transcorneal Permeation on Goat Cornea.
    Gade S; Patel KK; Gupta C; Anjum MM; Deepika D; Agrawal AK; Singh S
    J Pharm Sci; 2019 Sep; 108(9):2905-2916. PubMed ID: 30978345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system.
    Chen H; Pan H; Li P; Wang H; Wang X; Pan W; Yuan Y
    Colloids Surf B Biointerfaces; 2016 Jul; 143():455-462. PubMed ID: 27037783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Creatinine-based non-phospholipid vesicular carrier for improved oral bioavailability of Azithromycin.
    Ullah S; Shah MR; Shoaib M; Imran M; Shah SW; Ali I; Ahmed F
    Drug Dev Ind Pharm; 2017 Jun; 43(6):1011-1022. PubMed ID: 28157445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and In Vitro-Ex vivo Evaluation of Cannabidiol and Cannabidiol-Valine-Hemisuccinate Loaded Lipid-Based Nanoformulations for Ocular Applications.
    Adel Ali Youssef A; Hayder Abdelrahman M; Geweda MM; Varner C; Joshi PH; Ghonge M; Dudhipala N; Sulochana SP; Gadepalli RS; Majumdar S
    Int J Pharm; 2024 May; 657():124110. PubMed ID: 38604539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Niosomes for oral delivery of nateglinide: in situ-in vivo correlation.
    Sultan AA; El-Gizawy SA; Osman MA; El Maghraby GM
    J Liposome Res; 2018 Sep; 28(3):209-217. PubMed ID: 28618876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies.
    Abdelbary GA; Amin MM; Zakaria MY
    Drug Deliv; 2017 Nov; 24(1):309-319. PubMed ID: 28165809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.